Results 171 to 180 of about 2,384 (213)
Some of the next articles are maybe not open access.
Antiangiogenic effects of cucurbitacin-I
Archives of Pharmacal Research, 2014Cucurbitacin-I is a naturally occurring tetracyclic triterpenoid compound with diverse physiological actions that include inducing apoptosis and blocking cell cycle progression of various cancer cells. However, its antiangiogenic activity has not yet been examined.
Hyeon Jin, Kim, Jin-Kyung, Kim
openaire +2 more sources
Cucurbitacins of Colocynthis vulgaris
Phytochemistry, 1988Abstract The methanolic extract of the fruits of Colocynthis vulgaris on acidic hydrolysis afforded in addition to cucurbitacin I and J a new cucurbitacin designated cucurbitacin T whose structure was elucidated as (24 S )-16,24-anhydro-25-methoxy-2,16α,20β,24-tetrahydroxy-3,11,22-trioxocucurbita-1,5-diene by spectroscopic methods. The biosynthetic
Chandra B. Gamlath +4 more
openaire +1 more source
The biosynthesis of cucurbitacin B
Journal of the Chemical Society D: Chemical Communications, 1970Evidence is presented that is consistent with cucurbitacin B being biosynthesized via cycloartenol or parkeol but not through the intermediacy of lanosterol.
J. Malcolm Zander, Donald C. Wigfield
openaire +1 more source
Food and Chemical Toxicology, 2014
Cucurbitacin B, a member of the cucurbitaceae family, can act as a STAT3 signaling inhibitor to regulate the growth of hepatocellular carcinoma. STAT3 signaling has been shown to inhibit adipocyte differentiation through C/EBPα and PPARγ. Based on these studies, we hypothesized that cucurbitacin B would prevent PPARγ mediated adipocyte differentiation ...
Cho-Rong, Seo +12 more
openaire +2 more sources
Cucurbitacin B, a member of the cucurbitaceae family, can act as a STAT3 signaling inhibitor to regulate the growth of hepatocellular carcinoma. STAT3 signaling has been shown to inhibit adipocyte differentiation through C/EBPα and PPARγ. Based on these studies, we hypothesized that cucurbitacin B would prevent PPARγ mediated adipocyte differentiation ...
Cho-Rong, Seo +12 more
openaire +2 more sources
Cucurbitacin Contents in Hemsleya dolichocarpa
The American Journal of Chinese Medicine, 1991Hemsleya dolichocarpa was studied for its cucurbitacin contents during growing period. A colorimetric method was used to determine the total cucurbitacin levels, and a TLC densitometric assay was employed for estimating dihydrocucurbitacin F and its acetate, two active principles in Hemsleya plants. Cucurbitacin contents rise progressively from May to
P Q, Yang +4 more
openaire +2 more sources
Cucurbitacins as Anticancer Agents: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery, 2019Background: Cucurbitacins belong to a group of tetracyclic triterpenoids that display a wide range of biological effects. In the past, numerous cucurbitacins have been isolated from natural sources and many active compounds have been synthesized using the privileged scaffold in order to enhance its cytotoxic effects.
Hidayat, Hussain +5 more
openaire +2 more sources
Cucurbitacin glycosides from Caput nigri
Phytochemistry, 1995The chemical structures of cabenosides I-L were investigated. These are four of the 12 cucurbitacin glycosides isolated from 'Cabeça-de-negro', the roots of Caput nigri. By means of chemical analyses the structures of cabenosides I-L were elucidated as 10 alpha-cucurbit-5-ene-3 beta,11 alpha,20S,24 xi,25-pentaol [3, 25-di-O-beta-D-glucopyranoside, and ...
K, Nakano +3 more
openaire +2 more sources
Journal of Chromatography B, 2017
Cucurbitacin B (CuB) and cucurbitacin E (CuE) are tetracyclic triterpene compounds from Cucurbitaceae, and the main bioactive compounds of cucurbitacins tablets that used to treatment of chronic hepatitis. Pharmacological research has been very comprehensive, and there are few studies on pharmacokinetics, especially about CuE. An Ultra High Performance
Zhibin, Wang +8 more
openaire +2 more sources
Cucurbitacin B (CuB) and cucurbitacin E (CuE) are tetracyclic triterpene compounds from Cucurbitaceae, and the main bioactive compounds of cucurbitacins tablets that used to treatment of chronic hepatitis. Pharmacological research has been very comprehensive, and there are few studies on pharmacokinetics, especially about CuE. An Ultra High Performance
Zhibin, Wang +8 more
openaire +2 more sources
Bioremediation of Cucurbitacins from Cucurbitacin Phytonematicides
2022Phatu W. Mashela +4 more
openaire +1 more source
The stereochemistry of the cucurbitacins
Tetrahedron Letters, 1960David Lavie +2 more
openaire +1 more source

